Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2002

View Archived Issues

Aviron now part of MedImmune, expanding pipeline

Clinical testing of potentially safer amlodipine isomer begins at Sepracor

Clarinex tablets now available in U.S. pharmacies for SAR

Eos and Pharmacopeia decide not to merge

Prous Science announces new internet publication --Drug R&D Backgrounders: Sepsis and Septic Shock

QUATRx: a new biopharmaceutical company focusing on drugs targeting nuclear receptors

Another milestone reached in Celera Genomics/Aventis collaboration on cathepsin S inhibitors

Prana completes clinical stage of phase II Alzheimer's trial

MVA-Muc1-IL-2 enters phase II trials in lung and breast cancers

Single-dose EPI-2010 reduces need for bronchodilator medication in asthma patients

Nabi and Cankat sign Nabi-HB distribution agreement for Turkish market

Antibody research collaboration signed by Xenerex and DNAX Research

Merck's European C225 program progresses as planned despite U.S. setback

Frovatriptan completes mutual recognition procedure for E.U.-wide approval

Pieris and CytoTools collaborate to discover human Anticalins for atherosclerosis

Patient enrollment completed in trial of G17DT in gastric cancer

FDA approval granted for Eligard 7.5 mg, formerly Leuprogel One-Month Depot

TransDerm Technologies and Virotek to develop rapid lead poisoning detection test

Cognishunt system enters pivotal trials in AD patients

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Pyrazolotriazolopyrimidine derivatives with use in neurological diseases

Peptides with affinity for erythropoietin receptors useful in neurodegenerative disorders

Novel TNF-alpha production inhibitors identified at Santen

Sepracor scientists synthesize the four diastereomers of a piperidinyl-containing propionamide

Cell adhesion inhibitors described in patent by Tanabe Seiyaku

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...